First Header Logo Second Header Logo

Connection

Ralph D'Agostino to Arteriosclerosis

Back to Details
This is a "connection" page, showing publications Ralph D'Agostino has written about Arteriosclerosis.
Ralph D'Agostino
Connection Strength
1.118
Arteriosclerosis
  1. D'Agostino RB, Burke G, O'Leary D, Rewers M, Selby J, Savage PJ, Saad MF, Bergman RN, Howard G, Wagenknecht L, Haffner SM. Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study. Stroke. 1996 Oct; 27(10):1744-9.
    View in: PubMed
    Score: 0.141
  2. Karter AJ, D'Agostino RB, Mayer-Davis EJ, Wagenknecht LE, Hanley AJ, Hamman RF, Bergman R, Saad MF, Haffner SM. Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Obes Metab. 2005 May; 7(3):230-8.
    View in: PubMed
    Score: 0.064
  3. Goff DC, D'Agostino RB, Haffner SM, Otvos JD. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism. 2005 Feb; 54(2):264-70.
    View in: PubMed
    Score: 0.063
  4. Haffner SM, D'Agostino R, Festa A, Bergman RN, Mykkänen L, Karter A, Saad MF, Wagenknecht LE. Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors? Diabetes Care. 2003 Oct; 26(10):2796-803.
    View in: PubMed
    Score: 0.057
  5. Festa A, Hanley AJ, Tracy RP, D'Agostino R, Haffner SM. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation. 2003 Oct 14; 108(15):1822-30.
    View in: PubMed
    Score: 0.057
  6. Festa A, D'Agostino R, Tracy RP, Haffner SM. C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study. Diabet Med. 2002 Nov; 19(11):939-43.
    View in: PubMed
    Score: 0.054
  7. Hanley AJ, Karter AJ, Festa A, D'Agostino R, Wagenknecht LE, Savage P, Tracy RP, Saad MF, Haffner S. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes. 2002 Aug; 51(8):2642-7.
    View in: PubMed
    Score: 0.053
  8. Festa A, D'Agostino R, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001 Oct; 25(10):1407-15.
    View in: PubMed
    Score: 0.050
  9. Bell RA, Mayer-Davis EJ, Martin MA, D'Agostino RB, Haffner SM. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care. 2000 Nov; 23(11):1630-6.
    View in: PubMed
    Score: 0.047
  10. Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int. 2000 Oct; 58(4):1703-10.
    View in: PubMed
    Score: 0.046
  11. Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000 Jul 04; 102(1):42-7.
    View in: PubMed
    Score: 0.046
  12. Festa A, D'Agostino R, Mykkänen L, Tracy RP, Hales CN, Howard BV, Haffner SM. LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes Care. 1999 Oct; 22(10):1688-93.
    View in: PubMed
    Score: 0.043
  13. Festa A, D'Agostino R, Rautaharju P, O'Leary DH, Rewers M, Mykkänen L, Haffner SM. Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 1999 Aug; 30(8):1566-71.
    View in: PubMed
    Score: 0.043
  14. Haffner SM, D'Agostino R, Mykkänen L, Tracy R, Howard B, Rewers M, Selby J, Savage PJ, Saad MF. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 1999 Apr; 22(4):562-8.
    View in: PubMed
    Score: 0.042
  15. Festa A, D'Agostino R, Mykkänen L, Tracy RP, Zaccaro DJ, Hales CN, Haffner SM. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol. 1999 Mar; 19(3):562-8.
    View in: PubMed
    Score: 0.042
  16. Festa A, D'Agostino R, Mykkänen L, Tracy R, Howard BV, Haffner SM. Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study. Arterioscler Thromb Vasc Biol. 1999 Mar; 19(3):605-10.
    View in: PubMed
    Score: 0.042
  17. Haffner SM, D'Agostino R, Mykkänen L, Hales CN, Savage PJ, Bergman RN, O'Leary D, Rewers M, Selby J, Tracy R, Saad MF. Proinsulin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosclerosis Study. Stroke. 1998 Aug; 29(8):1498-503.
    View in: PubMed
    Score: 0.040
  18. Karter AJ, Mayer-Davis EJ, Selby JV, D'Agostino RB, Haffner SM, Sholinsky P, Bergman R, Saad MF, Hamman RF. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study. Diabetes. 1996 Nov; 45(11):1547-55.
    View in: PubMed
    Score: 0.035
  19. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkänen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes. 1996 Jun; 45(6):742-8.
    View in: PubMed
    Score: 0.034
  20. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB, Kempf J, Zinman B, Haffner SM. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2004 Oct; 53(10):2623-32.
    View in: PubMed
    Score: 0.015
  21. Williams K, Sniderman AD, Sattar N, D'Agostino R, Wagenknecht LE, Haffner SM. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2003 Nov 11; 108(19):2312-6.
    View in: PubMed
    Score: 0.014
  22. Festa A, D'Agostino R, Rich SS, Jenny NS, Tracy RP, Haffner SM. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation. 2003 May 20; 107(19):2422-7.
    View in: PubMed
    Score: 0.014
  23. Festa A, D'Agostino R, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2002 Apr; 51(4):1131-7.
    View in: PubMed
    Score: 0.013
  24. Hanley AJ, D'Agostino R, Wagenknecht LE, Saad MF, Savage PJ, Bergman R, Haffner SM. Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study. Diabetes. 2002 Apr; 51(4):1263-70.
    View in: PubMed
    Score: 0.013
  25. Haffner SM, D'Agostino R, Goff D, Howard B, Festa A, Saad MF, Mykkänen L. LDL size in African Americans, Hispanics, and non-Hispanic whites : the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol. 1999 Sep; 19(9):2234-40.
    View in: PubMed
    Score: 0.011
  26. Dubuisson JT, Wagenknecht LE, D'Agostino RB, Haffner SM, Rewers M, Saad MF, Laws A, Herrington DM. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes. Diabetes Care. 1998 Nov; 21(11):1790-6.
    View in: PubMed
    Score: 0.010
  27. Wagenknecht LE, D'Agostino RB, Haffner SM, Savage PJ, Rewers M. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 1998 Nov; 21(11):1812-8.
    View in: PubMed
    Score: 0.010
  28. Mayer-Davis EJ, D'Agostino R, Karter AJ, Haffner SM, Rewers MJ, Saad M, Bergman RN. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA. 1998 Mar 04; 279(9):669-74.
    View in: PubMed
    Score: 0.010
  29. Wagenknecht LE, D'Agostino R, Savage PJ, O'Leary DH, Saad MF, Haffner SM. Duration of diabetes and carotid wall thickness. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 1997 May; 28(5):999-1005.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.